Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Casirivimab
Small molecule
Emergency use authorization Experimental Antiviral Jan/23/2023
Imdevimab
Small molecule
Emergency use authorization Experimental Antiviral Jan/23/2023
T cells
Small molecule
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023
Remdesivir
Small molecule
Approved by FDA Experimental Antiviral Jan/18/2023
Sotrovimab
Small molecule
Emergency use authorization Experimental Antiviral Jul/14/2022
Nirmatrelvir
Small molecule
Emergency use authorization Experimental Antiviral Jun/23/2022
Bamlanivimab
Small molecule
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Etesevimab
Small molecule
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
S309
Small molecule
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/22/2022
BNT162b2
Small molecule
Approved by FDA Experimental Vaccine Jun/22/2022
mRNA-1273
Small molecule
Emergency use authorization Experimental Vaccine Jun/22/2022
REGEN-COV
Small molecule
Emergency use authorization Experimental Antiviral Jun/03/2022
Convalescent plasma
Small molecule
Emergency use authorization Experimental Antiviral May/16/2022
ACE2‐Fc
Small molecule
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/26/2022
Anakinra 
Small molecule
Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022
Ivermectin
Small molecule
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022
Baricitinib
Small molecule
Emergency use authorization Used to treat other disease Other treatment Feb/03/2022
Colchicine
Small molecule
Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/02/2022
Camptothecin
Small molecule
Potential treatment - theoretical effect Natural product Antiviral Jan/31/2022
PF-00835231
Small molecule
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022